Lifetime medical costs of knee osteoarthritis management in the United States: Impact of extending indications for total knee arthroplasty

Arthritis Care and Research

Volumn 67, Issue 2, 2015, Pages 203-215

  Losina, Elena ^a   Paltiel, A David ^b   Weinstein, Alexander M ^c   Yelin, Edward ^d   Hunter, David J ^e   Chen, Stephanie P ^c   Klara, Kristina ^c   Suter, Lisa G ^b,f   Solomon, Daniel H ^c   Burbine, Sara A ^c   Walensky, Rochelle P ^g   Katz, Jeffrey N ^c  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SYDNEY   (Australia)

^f VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPUTER SIMULATION; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; KNEE OSTEOARTHRITIS; MALE; MIDDLE AGED; TOTAL KNEE REPLACEMENT; TREATMENT INDICATION; UNITED STATES; AGED; ECONOMIC MODEL; ECONOMICS; HEALTH SERVICE; KNEE REPLACEMENT; OSTEOARTHRITIS, KNEE;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; OSTEOARTHRITIS, KNEE; UNITED STATES;

EID: 84922022282     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22412     Document Type: Article

References (82)

1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum 2008;58:26-35.
2. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol 1997;24:719-25.
3. Gabriel SE, Crowson CS, O'Fallon WM. Costs of osteoarthritis: estimates from a geographically defined population. J Rheumatol Suppl 1995;43:23-5.
4. Lanes SF, Lanza LL, Radensky PW, Yood RA, Meenan RF, Walker AM, et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum 1997;40:1475-81.
5. MacLean CH, Knight K, Paulus H, Brook RH, Shekelle PG. Costs attributable to osteoarthritis. J Rheumatol 1998;25:2213-8.
6. Mapel DW, Shainline M, Paez K, Gunter M. Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain. J Rheumatol 2004;31:573-83.
7. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012;64:465-74.
8. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62.
9. Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476-99.
10. Richmond J, Hunter D, Irrgang J, Jones MH, Snyder-Mackler L, Van Durme D, et al. American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis of the knee. J Bone Joint Surg Am 2010;92:990-3.
11. Richmond J, Hunter D, Irrgang J, Jones MH, Levy B, Marx R, et al. Treatment of osteoarthritis of the knee (nonarthroplasty). J Am Acad Orthop Surg 2009;17:591-600.
12. Weinstein AM, Rome BN, Reichmann WM, Collins JE, Burbine SA, Thornhill TS, et al. Estimating the burden of total knee replacement in the United States. J Bone Joint Surg Am 2013;95:385-92.
13. US Department of Health and Human Services. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project: nationwide inpatient sample. 2011. URL: http://hcupnet.ahrq.gov.
14. Coupe VM, Veenhof C, van Tulder MW, Dekker J, Bijlsma JW, Van den Ende CH. The cost effectiveness of behavioural graded activity in patients with osteoarthritis of hip and/or knee. Ann Rheum Dis 2007;66:215-21.
15. Fioravanti A, Valenti M, Altobelli E, Di Orio F, Nappi G, Crisanti A, et al. Clinical efficacy and cost-effectiveness evidence of spa therapy in osteoarthritis: the results of "naiade" Italian project. Panminerva Med 2003;45:211-7.
16. Kamath CC, Kremers HM, Vanness DJ, O'Fallon WM, Cabanela RL, Gabriel SE. The cost-effectiveness of acetaminophen, NSAIDs, and selective Cox-2 inhibitors in the treatment of symptomatic knee osteoarthritis. Value Health 2003;6:144-57.
17. Koskinen E, Eskelinen A, Paavolainen P, Pulkkinen P, Remes V. Comparison of survival and cost-effectiveness between unicondylar arthroplasty and total knee arthroplasty in patients with primary osteoarthritis: a follow-up study of 50,493 knee replacements from the Finnish Arthroplasty Register. Acta Orthop 2008;79:499-507.
18. Maetzel A, Krahn M, Naglie G. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis. Arthritis Rheum 2003;49:283-92.
19. Marshall JK, Pellissier JM, Attard CL, Kong SX, Marentette MA. Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective. Pharmacoeconomics 2001;19:1039-49.
20. Pope JE, Prashker M, Anderson J. The efficacy and cost effectiveness of n of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis. J Rheumatol 2004;31:140-9.
21. Reinhold T, Witt CM, Jena S, Brinkhaus B, Willich SN. Quality of life and cost-effectiveness of acupuncture treatment in patients with osteoarthritis pain. Eur J Health Econ 2008;9:209-19.
22. Sevick MA, Miller GD, Loeser RF, Williamson JD, Messier SP. Cost-effectiveness of exercise and diet in overweight and obese adults with knee osteoarthritis. Med Sci Sports Exerc 2009;41:1167-74.
23. Soohoo NF, Sharifi H, Kominski G, Lieberman JR. Cost-effectiveness analysis of unicompartmental knee arthroplasty as an alternative to total knee arthroplasty for unicompartmental osteoarthritis. J Bone Joint Surg Am 2006;88:1975-82.
24. Losina E, Thornhill TS, Rome BN, Wright J, Katz JN. The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic. J Bone Joint Surg Am 2012;94:201-7.
25. US Department of Health and Human Services. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project: nationwide inpatient sample. 1997. URL: http://hcupnet.ahrq.gov.
26. Holt HL, Katz JN, Reichmann WM, Gerlovin H, Wright EA, Hunter DJ, et al. Forecasting the burden of advanced knee osteoarthritis over a 10-year period in a cohort of 60-64 year-old US adults. Osteoarthritis Cartilage 2011;19:44-50.
27. Losina E, Walensky RP, Reichmann WM, Holt HL, Gerlovin H, Solomon DH, et al. Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Ann Intern Med 2011;154:217-26.
28. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253-8.
29. Berger A, Hartrick C, Edelsberg J, Sadosky A, Oster G. Direct and indirect economic costs among private-sector employees with osteoarthritis. J Occup Environ Med 2011;53:1228-35.
30. US Department of Labor. Bureau of Labor Statistics. Economic news release. Table A-6: employment status of the civilian population by sex, age, and disability status, not seasonally adjusted. 2013. URL: http://www.bls.gov/news.release/empsit.t06.htm.
31. Losina E, Walensky RP, Kessler CL, Emrani PS, Reichmann WM, Wright EA, et al. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med 2009;169:1113-21.
32. Losina E, Weinstein AM, Reichmann WM, Burbine SA, Solomon DH, Daigle ME, et al. Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US. Arthritis Care Res (Hoboken) 2013;65:703-11.
33. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957;16:494-502.
34. US Department of Health and Human Services. Centers for Disease Control and Prevention. Health Data Interactive. URL: http://www.cdc.gov/nchs/hdi.htm.
35. Arias E. National vital statistics reports: United States life tables, 2009. Centers for Disease Control and Prevention. URL: http://www.cdc.gov/nchs/products/nvsr.htm#vol62.
36. US Department of Health and Human Services. Centers for Disease Control and Prevention. National Health Interview Survey, 2010 Data Release. URL: http://www.cdc.gov/nchs/nhis/nhis-2010-data-release.htm.
37. Suter LG, Paltiel AD, Rome BN, Solomon DH, Thornhill TS, Abrams SK, et al. Placing a price on medical device innovation: the example of total knee arthroplasty. PLoS One 2013;8:e62709.
38. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-15.
39. Wise BL, Felson DT, Clancy M, Niu J, Neogi T, Lane NE, et al. Consistency of knee pain and risk of knee replacement: the Multicenter Osteoarthritis Study. J Rheumatol 2011;38:1390-5.
40. US Department of Health and Human Services. National Institutes of Health. Osteoarthritis Initiative. URL: http://oai.epi-ucsf.org/datarelease/default.asp.
41. US Department of Health and Human Services. Centers for Disease Control and Prevention. National Health Interview Survey, 2012 Data Release. URL: http://www.cdc.gov/nchs/nhis/nhis-2012-data-release.htm.
42. National Health and Nutrition Examination Survey 2009-2010. Hyattsville (MD): US Department of Health and Human Services/National Center for Health Statistics; 2010.
43. Raynauld JP, Buckland-Wright C, Ward R, Choquette D, Haraoui B, Martel-Pelletier J, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2003;48:370-7.
44. Scott DL, Berry H, Capell H, Coppock J, Daymond T, Doyle DV, et al. The long-term effects of non-steroidal antiinflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial. Rheumatology (Oxford) 2000;39:1095-101.
45. Centers for Medicare & Medicaid Services. Medicare Current Beneficiary Survey. 2009. URL: http://www.cms.gov/Research-Statistics-Data-and-Systems/Research/MCBS/index.html.
46. Katz JN, Mahomed NN, Baron JA, Barrett JA, Fossel AH, Creel AH, et al. Association of hospital and surgeon procedure volume with patient-centered outcomes of total knee replacement in a population-based cohort of patients age 65 years and older. Arthritis Rheum 2007;56:568-74.
47. Paxton EW, Namba RS, Maletis GB, Khatod M, Yue EJ, Davies M, et al. A prospective study of 80,000 total joint and 5,000 anterior cruciate ligament reconstruction procedures in a community-based registry in the United States. J Bone Joint Surg Am 2010;92 Suppl 2:117-32.
48. US Department of Labor. Bureau of Labor Statistics. Consumer Price Index. URL: http://www.bls.gov/cpi/#data.
49. Red Book Online. Truven Health Analytics Inc. 2014. URL: http://micromedex.com/redbook.
50. Centers for Medicare & Medicaid Services. Medicare fee schedules. 2012. URL: http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PFSlookup/index.html.
51. Centers for Medicare & Medicaid Services. Hospital outpatient prospective payment system. URL: http://www.cms.gov/HospitalOutpatientPPS/.
52. Centers for Medicare & Medicaid Services. MEDPAR 2011. URL: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/MedicareFeeforSvcPartsAB/MEDPAR.html.
53. Buntin MB, Deb P, Escarce J, Hoverman C, Paddock S, Sood N. Comparison of Medicare spending and outcomes for beneficiaries with lower extremity joint replacements. Santa Monica (CA): RAND Health; 2005.
54. Teeny SM, York SC, Mesko JW, Rea RE. Long-term follow-up care recommendations after total hip and knee arthroplasty: results of the American Association of Hip and Knee Surgeons' member survey. J Arthroplasty 2003;18:954-62.
55. White AG, Birnbaum HG, Janagap C, Buteau S, Schein J. Direct and indirect costs of pain therapy for osteoarthritis in an insured population in the United States. J Occup Environ Med 2008;50:998-1005.
56. Xie F, Thumboo J, Li SC. True difference or something else? Problems in cost of osteoarthritis studies. Semin Arthritis Rheum 2007;37:127-32.
57. Liang MH, Larson M, Thompson M, Eaton H, McNamara E, Katz R, et al. Costs and outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1984;27:522-9.
58. Lee DW, Meyer JW, Clouse J. Implications of controlling for comorbid conditions in cost-of-illness estimates: a case study of osteoarthritis from a managed care system perspective. Value Health 2001;4:329-34.
59. Messier SP, Loeser RF, Miller GD, Morgan TM, Rejeski WJ, Sevick MA, et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis Rheum 2004;50:1501-10.
60. Fortin PR, Penrod JR, Clarke AE, St-Pierre Y, Joseph L, Belisle P, et al. Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. Arthritis Rheum 2002;46:3327-30.
61. Fortin PR, Clarke AE, Joseph L, Liang MH, Tanzer M, Ferland D, et al. Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum 1999;42:1722-8.
62. Desmeules F, Dionne CE, Belzile EL, Bourbonnais R, Champagne F, Fremont P. Determinants of pain, functional limitations and health-related quality of life six months after total knee arthroplasty: results from a prospective cohort study. BMC Sports Sci Med Rehabil 2013;5:2.
63. Keurentjes JC, Fiocco M, So-Osman C, Onstenk R, Koopman-Van Gemert AW, Poll RG, et al. Patients with severe radiographic osteoarthritis have a better prognosis in physical functioning after hip and knee replacement: a cohort-study. PLoS One 2013;8:e59500.
64. Schnurr C, Jarrous M, Gudden I, Eysel P, Konig DP. Preoperative arthritis severity as a predictor for total knee arthroplasty patients' satisfaction. Int Orthop 2013;37:1257-61.
65. Dowsey MM, Nikpour M, Dieppe P, Choong PF. Associations between pre-operative radiographic changes and outcomes after total knee joint replacement for osteoarthritis. Osteoarthritis Cartilage 2012;20:1095-102.
66. Dy CJ, Marx RG, Bozic KJ, Pan TJ, Padgett DE, Lyman S. Risk factors for revision within 10 years of total knee arthroplasty. Clin Orthop Relat Res 2014;472;1198-207.
67. Julin J, Jamsen E, Puolakka T, Konttinen YT, Moilanen T. Younger age increases the risk of early prosthesis failure following primary total knee replacement for osteoarthritis: a follow-up study of 32,019 total knee replacements in the Finnish Arthroplasty Register. Acta Orthop 2010;81:413-9.
68. Mahomed NN, Liang MH, Cook EF, Daltroy LH, Fortin PR, Fossel AH, et al. The importance of patient expectations in predicting functional outcomes after total joint arthroplasty. J Rheumatol 2002;29:1273-9.
69. Gandhi R, Davey JR, Mahomed NN. Predicting patient dissatisfaction following joint replacement surgery. J Rheumatol 2008;35:2415-8.
70. Dowsey MM, Liew D, Stoney JD, Choong PF. The impact of pre-operative obesity on weight change and outcome in total knee replacement: a prospective study of 529 consecutive patients. J Bone Joint Surg Br 2010;92:513-20.
71. Pope GC, Kautter J, Ellis RP, Ash AS, Ayanian JZ, Lezzoni LI, et al. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev 2004;25:119-41.
72. The use of medicines in the United States: review of 2010. Parsippany (NJ): IMS Institute for Healthcare Informatics; 2011.
73. US Department of Health and Human Services. Office of Inspector General. Medicaid drug price comparison: average sales price to average wholesale price. 2005. URL: http://oig.hhs.gov/oei/reports/oei-03-05-00200.pdf.
74. Grindrod KA, Marra CA, Colley L, Cibere J, Tsuyuki RT, Esdaile JM, et al. After patients are diagnosed with knee osteoarthritis, what do they do? Arthritis Care Res (Hoboken) 2010;62:510-15.
75. Van der Esch M, Heijmans M, Dekker J. Factors contributing to possession and use of walking aids among persons with rheumatoid arthritis and osteoarthritis. Arthritis Care Res 2003;49:838-42.
76. Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc 1999;74:1095-105.
77. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005;352:1071-80.
78. Goldstein JL, Silverstein FE, Agrawal NM, Hubbard RC, Kaiser J, Maurath CJ, et al. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel Cox-2 inhibitor. Am J Gastroenterol 2000;95:1681-90.
79. Silverstein FE, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittman RM, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:241-9.
80. Yen ZS, Lai MS, Wang CT, Chen LS, Chen SC, Chen WJ, et al. Cost-effectiveness of treatment strategies for osteoarthritis of the knee in Taiwan. J Rheumatol 2004;31:1797-803.
81. Ayral X. Injections in the treatment of osteoarthritis. Best Pract Res Clin Rheumatol 2001;15:609-26.
82. Katz JN, Barrett J, Mahomed NN, Baron JA, Wright RJ, Losina E. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am 2004;86:1909-16.